Table 1 Baseline characteristics of patients.

From: Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan

 

1996–2007 (n = 505)

2008–2019 (n = 355)

Total (n = 860)

p

n

% or range

n

%

n

%

Gender

      

0.487

Male

275

54.46

202

56.9

477

55.47

 

Female

230

45.54

153

43.1

383

44.53

 

Age

      

0.173

Median, range

8.56

0–18

10.64

0–18

9.48

0–18

 

WBC (k/ml)

      

0.016

Median, range

27.36

0.7–726

21.58

0.5–639.4

23.6

0.5–726

 

FAB

      

0.008

M0

26

5.15

14

3.94

40

4.65

 

M1

65

12.87

43

12.11

108

12.56

 

M2

151

29.9

112

31.55

263

30.58

 

M4

80

15.84

62

17.46

142

16.51

 

M5

62

12.28

53

14.93

115

13.37

 

M6

18

3.56

8

2.25

26

3.02

 

M7

54

10.69

39

10.99

93

10.81

 

M8

0

0

1

0.28

1

0.12

 

M9

20

3.96

21

5.92

41

4.77

 

Unknown

29

5.74

2

0.56

31

3.6

 

Chromosome

      

< 0.0001

-5/del(5q)/-7/del(7q)

11

2.18

8

2.25

19

2.21

 

11q23

14

2.77

12

3.38

26

3.02

 

Complex

34

6.73

32

9.01

66

7.67

 

N/A

127

25.15

26

7.32

153

17.79

 

Normal

130

25.74

91

25.63

221

25.7

 

Other

83

16.44

76

21.41

159

18.49

 

inv(16)

17

3.37

20

5.63

37

4.3

 

t(6;9)

4

0.79

0

0

4

0.47

 

t(8;21)

74

14.65

69

19.44

143

16.63

 

t(9;11)

8

1.58

20

5.63

28

3.26

 

t(9;22)

3

0.59

1

0.28

4

0.47

 
  1. FAB: French–American–British, WBC: white blood cell.